Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Minerva Biotechnologies
Minerva Biotechnologies Announces Major Stem Cell Breakthrough
October 14th, 2008
Minerva Biotechnologies, a leading nanotechnology, cancer and stem cell development company announced a major breakthrough in stem cell research. Minerva and collaborators at the University of California at Santa Barbara discovered that a single, new growth factor can not only support massive growth of human embryonic stem cells (hESCs) in vitro, but also maintains them in a nearly 100% undifferentiated state without the need for fibroblast "feeder cells". This represents a major step forward for potential stem cell therapies as well as in the basic understanding of the mechanisms that regulate stem cell growth and differentiation. Their study, "MUC1* Mediates the...
Source: Cancer Weekly (2008-10-14)
|
